Production of complementary DNA representing hepatitis A viral sequences by recombinant DNA methods and uses therefor
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsRobert H. Purcell, Suzanne U. Emerson
Life of this patent
Estimating the term…
Abstract
Methods for producing HAV cDNA, products thereof, and uses thereof, are described. HAV cDNA is produced, for example, by reverse transcribing HAV RNA and subsequently inserting the HAV cDNA into bacterial plasmids by genetic-engineering techniques. Transformed bacteria are then cloned and cultured to produce replicated chimeric plasmids containing the HAV cDNA. Such HAV cDNA is useful in assaying for the presence of HAV and in the production of HAV antigen and in the production of antibodies against HAV.
Claims10
A DNA construct consisting of the genome of a hepatitis A virus, which genome is of a wild-type hepatitis A virus except for the P2 region, which P2 region is from a cell culture-adapted hepatitis A virus.
A hepatitis A virus having a genome consisting of a wild-type hepatitis A virus genome except for the P2 region, which P2 region is from a cell culture-adapted hepatitis A virus.
A DNA construct consisting of the genome of a hepatitis A virus, which genome is of a wild-type hepatitis A virus except for the P2 and 5' noncoding regions, which P2 and 5' noncoding regions are from a cell culture-adapted hepatitis A virus.
A hepatitis A virus having a genome of a hepatitis A virus, which genome is of a wild-type hepatitis A virus except for the P2 and 5' noncoding regions, which P2 and 5' noncoding regions are from a cell culture-adapted hepatitis A virus.
Dependencies are inferred from the claim text.